Ocular Therapeutix, Inc.
DE ˙ DB ˙ US67576A1007
7,15 € ↑0,25 (3,62%)
2026-06-04
DEL PRIS
SecurityDE:0OT / Ocular Therapeutix, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership4,708,419 shares
Latest Disclosed Value $ 39,880,309
State Street Corp reports 12.20% increase in ownership of 0OT / Ocular Therapeutix, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 4,708,419 shares of Ocular Therapeutix, Inc. (DE:0OT) valued at $31,282,736 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,196,330 shares of Ocular Therapeutix, Inc.. This represents a change in shares of 12.20% during the quarter. The current value of the position is $33,665,196 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 4,708,419 512,089 12.20 39,880 -21.72 0.0014
2026-02-13 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 4,196,330 736,318 21.28 50,943 25.95 0.0017
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 3,460,012 -49,098 -1.40 40,448 24.21 0.0014
2025-08-14 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 3,509,110 117,260 3.46 32,565 30.98 0.0012
2025-05-15 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 3,391,850 -98,039 -2.81 24,862 -16.58 0.0010
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 3,489,889 13,597 0.39 29,804 -1.45 0.0012
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 3,476,292 -444,371 -11.33 30,244 12.78 0.0012
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 3,920,663 1,518,283 63.20 26,817 22.67 0.0012
2024-05-15 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 2,402,380 862,805 56.04 21,862 218.39 0.0010
2024-02-14 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,539,575 -242,290 -13.60 6,867 22.72 0.0003
2023-11-14 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,781,865 205,652 13.05 5,595 -31.21 0.0003
2023-08-14 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,576,213 83,254 5.58 8,133 3.38 0.0004
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,492,959 105,627 7.61 7,868 101.82 0.0004
2023-05-15 2022-12-31 13F/A-99 OCULAR THERAPEUTIX COM 67576A100 1,387,332 -12,014 -0.86 3,898 -32.87 0.0002
2023-05-15 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,387,332 -12,014 3,898 0.0002
2022-11-15 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,399,346 -12,481 -0.88 5,807 2.31 0.0004
2022-08-15 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,411,827 -293,107 -17.19 5,676 -32.74 0.0003
2022-05-16 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,704,934 -25,422 -1.47 8,439 -30.03 0.0004
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,730,356 57,306 3.43 12,061 -27.91 0.0006
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,673,050 -65,422 -3.76 16,731 -32.13 0.0009
2021-08-16 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,738,472 220,855 14.55 24,652 -1.01 0.0013
2021-07-09 2021-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 1,517,617 62,663 4.31 24,904 -17.31 0.0014
2021-05-17 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,517,617 62,663 24,904 0.0014
2021-02-16 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,454,954 305,487 26.58 30,118 244.32 0.0018
2020-11-10 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,149,467 243,485 26.88 8,747 15.90 0.0006
2020-08-14 2020-06-30 13F OCULAR THERAPEUTIX COM 67576A100 905,982 89,781 11.00 7,547 86.81 0.0005
2020-06-19 2020-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 816,201 109,634 15.52 4,040 44.75 0.0004
2020-05-11 2020-03-31 13F OCULAR THERAPEUTIX COM 67576A100 816,201 109,634 4,040 354.7933
2020-02-06 2019-12-31 13F OCULAR THERAPEUTIX COM 67576A100 706,567 33,671 5.00 2,791 36.41 0.0002
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX COM 67576A100 672,896 92,165 15.87 2,046 -19.92 0.0002
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX COM 67576A100 580,731 59,405 11.39 2,555 23.43 0.0002
2019-05-15 2019-03-31 13F OCULAR THERAPEUTIX COM 67576A100 521,326 36,649 7.56 2,070 7.31 0.0002
2019-02-12 2018-12-31 13F OCULAR THERAPEUTIX COM 67576A100 484,677 11,383 2.41 1,929 -40.76 0.0002
2018-11-09 2018-09-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 473,294 40,314 9.31 3,256 11.35 0.0003
2018-08-14 2018-06-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 432,980 59,057 15.79 2,924 19.89 0.0002
2018-05-15 2018-03-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 373,923 21,782 6.19 2,439 55.85 0.0002
2018-02-14 2017-12-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 352,141 261 0.07 1,565 -28.08 0.0001
2017-11-14 2017-09-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 351,880 -20,043 -5.39 2,176 -36.93 0.0002
2017-08-14 2017-06-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 371,923 40,782 12.32 3,450 12.16 0.0003
2017-05-15 2017-03-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 331,141 92,220 38.60 3,076 53.80 0.0003
2017-02-09 2016-12-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 238,921 42,761 21.80 2,000 48.15 0.0002
2017-01-13 2016-09-30 13F/A-1 OCULAR THERAPEUTIX Common equity shares 67576A100 196,160 -9,149 -4.46 1,350 33.14 0.0001
2016-11-14 2016-09-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 196,160 1,350
2016-08-12 2016-06-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 205,309 -277 -0.13 1,014 -49.02 0.0001
2016-05-20 2016-03-31 13F/A-1 OCULAR THERAPEUTIX Common equity shares 67576A100 205,586 24,939 13.81 1,989 17.41 0.0002
2016-05-12 2016-03-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 205,586 1,989
2016-02-16 2015-12-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 180,647 3,698 2.09 1,694 -31.83 0.0002
2015-11-16 2015-09-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 176,949 52,049 41.67 2,485 -5.37 0.0003
2015-08-13 2015-06-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 124,900 54,771 78.10 2,626 -10.77 0.0003
2015-05-15 2015-03-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 70,129 23,029 48.89 2,943 165.61 0.0003
2015-02-11 2014-12-31 13F OCULAR THERAPEUTIX Common equity shares 67576A100 47,100 7,200 18.05 1,108 85.91 0.0001
2014-11-12 2014-09-30 13F/A-1 OCULAR THERAPEUTIX Common equity shares 67576A100 39,900 39,900 596 0.0001
2014-11-10 2014-09-30 13F OCULAR THERAPEUTIX Common equity shares 67576A100 39,900 596 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.